Propionylpromazine: Unveiling a Novel Inhibitory Agent Against Mycobacterium tuberculosis
U. Suresh, M. Punnam, C. Kartick, A. P. Sugunan
This study identifies propionylpromazine as a potent inhibitor of Mycobacterium tuberculosis growth in vitro and within macrophages, suggesting its potential as a new therapeutic agent.
bioRxiv · Apr 16, 2024 · PreprintMicrobiology